Weight Loss
Best peptides for weight loss.
Weight loss peptides — particularly GLP-1 and dual GLP-1/GIP agonists — work by regulating appetite, slowing gastric emptying, and improving insulin sensitivity. They have become some of the most studied compounds in modern metabolic medicine.
9 peptides in this category
A long-acting GLP-1 receptor agonist studied for its effects on appetite, satiety, and glucose regulation.
A dual GIP and GLP-1 receptor agonist with strong effects on appetite, glucose handling, and body composition.
An investigational triple agonist of GLP-1, GIP, and glucagon receptors producing some of the largest weight-loss results recorded in trials.
A small-molecule oral GLP-1 receptor agonist studied as a needle-free alternative to injectable incretin therapy.
A modified C-terminal fragment of human growth hormone designed for fat-loss effects without the broader anabolic action of full HGH.
A long-acting amylin analog developed to be combined with semaglutide for enhanced weight loss (CagriSema).
A dual GLP-1 / glucagon receptor agonist developed by Innovent and Eli Lilly for type 2 diabetes and weight loss.
A weekly dual GLP-1 / glucagon receptor agonist developed by Boehringer Ingelheim and Zealand Pharma for obesity and MASH.
A targeted chimeric peptide that triggers apoptosis in blood vessels supplying white adipose tissue, producing rapid fat loss in animal studies.
What to know about weight loss peptides
Weight loss peptides — particularly GLP-1 and dual GLP-1/GIP agonists — work by regulating appetite, slowing gastric emptying, and improving insulin sensitivity. They have become some of the most studied compounds in modern metabolic medicine. Each peptide in this category is profiled individually with its mechanism of action, typical dosing information, and known side-effect profile. Click any peptide to explore the full breakdown.
For research planning, pair this directory with our Dosage Calculator and Reconstitution Calculator.